Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry

Colin H. Holtze; Elizabeth A. Freiheit; Susan L. Limb; John L. Stauffer; Karina Raimundo; Wayne T. Pan; Kevin R. Flaherty; Hyun J. Kim

doi:10.1186/s12931-020-1315-4

Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry

Colin H. Holtze, Elizabeth A. Freiheit, Susan L. Limb, John L. Stauffer, Karina Raimundo, Wayne T. Pan, Kevin R. Flaherty, Hyun J. Kim

Medicine - Pulmonary, Allergy, Critical

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Original language	English (US)
Journal	Respiratory research
Volume	21
Issue number	1
DOIs	https://doi.org/10.1186/s12931-020-1315-4
State	Published - Dec 1 2020

PubMed: MeSH publication types

Journal Article

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1186/s12931-020-1315-4

https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-020-1315-4

OpenUrl availability

Full text

Cite this

Holtze, C. H., Freiheit, E. A., Limb, S. L., Stauffer, J. L., Raimundo, K., Pan, W. T., Flaherty, K. R., & Kim, H. J. (2020). Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry. Respiratory research, 21(1). https://doi.org/10.1186/s12931-020-1315-4

Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry. / Holtze, Colin H.; Freiheit, Elizabeth A.; Limb, Susan L. et al.
In: Respiratory research, Vol. 21, No. 1, 01.12.2020.

Research output: Contribution to journal › Article › peer-review

Holtze, CH, Freiheit, EA, Limb, SL, Stauffer, JL, Raimundo, K, Pan, WT, Flaherty, KR & Kim, HJ 2020, 'Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry', Respiratory research, vol. 21, no. 1. https://doi.org/10.1186/s12931-020-1315-4

@article{a6427a6a1f124b2ca18e64f756a3a1ff,

title = "Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry",

author = "Holtze, {Colin H.} and Freiheit, {Elizabeth A.} and Limb, {Susan L.} and Stauffer, {John L.} and Karina Raimundo and Pan, {Wayne T.} and Flaherty, {Kevin R.} and Kim, {Hyun J.}",

year = "2020",

month = dec,

day = "1",

doi = "10.1186/s12931-020-1315-4",

language = "English (US)",

volume = "21",

journal = "Respiratory research",

issn = "1465-9921",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry

AU - Holtze, Colin H.

AU - Freiheit, Elizabeth A.

AU - Limb, Susan L.

AU - Stauffer, John L.

AU - Raimundo, Karina

AU - Pan, Wayne T.

AU - Flaherty, Kevin R.

AU - Kim, Hyun J.

PY - 2020/12/1

Y1 - 2020/12/1

U2 - 10.1186/s12931-020-1315-4

DO - 10.1186/s12931-020-1315-4

M3 - Article

C2 - 32041621

SN - 1465-9921

VL - 21

JO - Respiratory research

JF - Respiratory research

IS - 1

ER -